Skip to main content

Table 4 Sensitivity and specificity of normalized MALAT1 and number of true-positive, true-negative, false-positive, and false-negative tests, calculated for different false positive rates (FPR), i.e., none, one, and two false-positive tests and maximum Youden’s Index (YI)

From: Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer

  

Cutoff

Sensitivity (%)

Specificity (%)

True-positive (N)

True-negative (N)

False-positive (N)

False-negative (N)

NSCLC vs. controls

FPR = 0%

-0.24

47

100

21

25

0

24

 

FPR = 4%

-0.41

56

96

25

24

1

20

 

FPR = 8%

-0.42

56

92

25

23

2

20

 

Maximum YI

-0.41

56

96

25

24

1

20

AdCa vs. controls

FPR = 0%

-0.05

38

100

8

25

0

13

 

FPR = 4%

-0.35

48

96

10

24

1

11

 

FPR = 8%

-0.42

48

92

10

23

2

11

 

Maximum YI

-1.44

81

64

17

16

9

4

SqCC vs. controls

FPR = 0%

-0.24

54

100

13

25

0

11

 

FPR = 4%

-0.41

63

96

15

24

1

9

 

FPR = 8%

-0.42

63

92

15

23

2

9

 

Maximum YI

-0.41

63

96

15

24

1

9

AdCa vs. SqCC

FPR = 0%

3.37

8

100

2

21

0

22

 

FPR = 5%

2.76

8

95

2

20

1

22

 

FPR = 10%

1.91

21

90

5

19

2

19

 

Maximum YI

1.32

33

86

8

18

3

16